Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Jenna A. Moran"'
Autor:
Marla M. Jalbut, Aliyah R. Sohani, Paola Dal Cin, Robert P. Hasserjian, Jenna A. Moran, Andrew M. Brunner, Amir T. Fathi
Publikováno v:
Leukemia Research Reports, Vol 4, Iss 1, Pp 28-30 (2015)
Klinefelter syndrome (KS), a 47,XXY chromosomal abnormality, has been shown to be associated with a number of malignancies, but has not been linked to acute leukemias to date. We present a case of a 54-year-old male diagnosed with acute myeloid leuke
Externí odkaz:
https://doaj.org/article/d3fe72b812924c55a29e2f6372dc3ee1
Autor:
Kevin C. Miller, Jennifer Lombardi Story, Julia Foster, Jenna A. Moran, Amir T. Fathi, Gabriela S. Hobbs
Publikováno v:
Blood. 140:12295-12296
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15938bdd24096ff05d1b55462012ebdb
https://doi.org/10.1182/blood-2022-170986
https://doi.org/10.1182/blood-2022-170986
Autor:
Jenna A. Moran, Philip C. Amrein, Chrisa Hunnewell, Amir T. Fathi, Meghan Bergeron, Timothy A. Graubert, Valentina Nardi, Julia Foster, Andrew M. Brunner, Keagan S Casey, Maristela L. Onozato, Vinayak Venkataraman, Steven L. McAfee, Matthew J. Frigault, Gabriela S. Hobbs, Hanno Hock, Paola Dal Cin
Publikováno v:
Leukemia. 34:3050-3054
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1ebf1302017ea4b10911e77162cc3c7
https://doi.org/10.1038/s41375-020-0983-x
https://doi.org/10.1038/s41375-020-0983-x
Autor:
Rupa Narayan, Robert P. Hasserjian, Margaret C. Wey, Tanya T. Behnan, Meghan Bergeron, Jessica Rae, Mason L. Mann, Ashkan Emadi, Christina Bertoli, Eyal C. Attar, Traci M. Blonquist, Christopher Lescinskas, Jenna A. Moran, Yi-Bin Chen, Steven L. McAfee, Vu H. Duong, Patricia Lesho, Timothy A. Graubert, Jennifer Lombardi Story, Andrew M. Brunner, Meghan Burke, Megan K. Vartanian, Gabriela S. Hobbs, Tina T. Som, Donna Neuberg, Hanno Hock, Molly Macrae, Julia Foster, Kristin McGregor, Philip C. Amrein, Amir T. Fathi, Karen K. Ballen, Frederic I. Preffer, Aura Y. Ramos, Christine Connolly
Publikováno v:
Cancer. 126:1264-1273
Background Outcomes for patients with relapsed/refractory acute myeloid leukemia (R/R AML) remain poor. Novel therapies specifically targeting AML are of high interest. Brentuximab vedotin (BV) is an antibody-drug conjugate that is specific for human
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::411429856bce3fe963798cabff48aa70
https://doi.org/10.1002/cncr.32657
https://doi.org/10.1002/cncr.32657
Autor:
Jenna A. Moran, John A. Branda, Sarah P. Hammond, Lyn M. Duncan, Julian A. Villalba, Nathan P. Wiederhold, Amir T. Fathi, Steven T. Chen, Devanshi Mehta, Connie Cañete-Gibas, Samuel A Hofacker, Jessica Cervantes
Publikováno v:
Open Forum Infectious Diseases
Certain Penicillium species are emerging opportunistic pathogens. While these can be common causes of airborne contamination of clinical cultures, an increasing number of reports describe clinically significant disease in the immunocompromised popula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ac35600a88a04f1267ff822fce303ba
https://doi.org/10.1093/ofid/ofab265
https://doi.org/10.1093/ofid/ofab265
Autor:
Vinod Pullarkat, Jenna A. Moran, Nuthana Naidoo, Jennifer Lombardi, Guido Marcucci, Ibrahim Aldoss, Shukaib Arslan, Amir T. Fathi, Prajwal Dhakal, Anthony S. Stein, George Yaghmour, Vijaya Raj Bhatt, Jianying Zhang
Publikováno v:
American Journal of Hematology. 96
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0ecb3e905830d99f417e3127469ebcb
https://doi.org/10.1002/ajh.26057
https://doi.org/10.1002/ajh.26057
Autor:
Tina T. Som, Malgorzata McMasters, Philip C. Amrein, Kaitlyn M. Fishman, Daniela Hernandez, Gabriela S. Hobbs, Andrew M. Brunner, Robin Joyce, Kristin McGregor, Karen K. Ballen, Meghan Bergeron, Donna Neuberg, Traci M. Blonquist, Jessica Rae, Ashley M. Perry, David Avigan, Tanya T. Behnan, Mark J. Levis, Jenna A. Moran, Amir T. Fathi, Meghan Burke, Christine Connolly, Aura Y. Ramos, Christelle Joseph, Julia Foster, Emma Logan
Publikováno v:
Cancer. 124:306-314
BACKGROUND Cabozantinib, a tyrosine kinase inhibitor of FMS-like tyrosine kinase 3 (FLT3), MET, AXL, vascular endothelial growth factor receptor, and KIT, is approved for use in multiple malignancies. We assessed the safety and tolerability of caboza
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65f71b564f4aebcc1cba78f2d092bb55
https://doi.org/10.1002/cncr.31038
https://doi.org/10.1002/cncr.31038
Autor:
Jenna A. Moran, Catherine C. Smith, Rupa Narayan, Koichi Takahashi, Meghan Bergeron, Amir T. Fathi, Alexander E. Perl, Courtney D. DiNardo, Andrew M. Brunner, Mark J. Levis, Hanno Hock, Philip C. Amrein, Julia Foster, Gabriela S. Hobbs, Naval Daver
Publikováno v:
Blood. 136:11-12
Characterization of pathogenic alterations in acute myeloid leukemia (AML) has led to development of promising targeted therapies, including FLT3 (FLT3i) and IDH1/2 inhibitors (IDHi), with several approved for use; midostaurin (MIDO), gilteritinib, e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fed5031ca513edb15ca5ceb78d581621
https://doi.org/10.1182/blood-2020-140118
https://doi.org/10.1182/blood-2020-140118
Autor:
Philip C. Amrein, Karen K. Ballen, Kristen E. Stevenson, Traci M. Blonquist, Andrew M. Brunner, Gabriela S. Hobbs, Hanno R. Hock, Steven L. McAfee, Jenna A. Moran, Meghan Bergeron, Julia E. Foster, Christina Bertoli, Kristin McGregor, Molly Macrae, Meghan Burke, Tanya T. Behnan, Tina T. Som, Aura Y. Ramos, Megan K. Vartanian, Jennifer Lombardi Story, Christine Connolly, Timothy A. Graubert, Donna S. Neuberg, Amir T. Fathi
Publikováno v:
Blood. 136:41-42
Introduction: While progress has been made in the treatment of childhood leukemia, the outlook for patients >60 years of age with acute lymphoblastic leukemia (ALL) is poor with complete remission rates (CR) of approximately 60% and 3-year survivals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b5a9a8ee179324f02f38b573e178d79
https://doi.org/10.1182/blood-2020-139661
https://doi.org/10.1182/blood-2020-139661
Autor:
Julia Foster, Rupa Narayan, Meghan Bergeron, Hanno Hock, Amir T. Fathi, Aura Y. Ramos, Philip C. Amrein, Andrew M. Brunner, Siyang Ren, Jennifer Lombardi Story, Tina T. Som, Donna Neuberg, Yi-Bin Chen, Megan K. Vartanian, Jenna A. Moran, Gabriela S. Hobbs, Chi-Joan How
Publikováno v:
Blood. 136:5-6
BACKGROUND: Angiogenesis is increasingly known to play a role in pathogenesis of hematologic malignancies, including myeloid neoplasms. Regorafenib is a multikinase inhibitor that targets angiogenic, stromal and oncogenic kinases including VEGF- 1, 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e5e7b0a57ce9779fd1750514e597bff
https://doi.org/10.1182/blood-2020-140278
https://doi.org/10.1182/blood-2020-140278